69 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
met or removed to the Company’s satisfaction, (ii) as determined by the Company, all other legal matters regarding the issuance and delivery … satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation
8-K
EX-99.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
conditions, the satisfaction of customary closing conditions related to the private placement and the anticipated use of proceeds therefrom, and plans … associated with market conditions and the satisfaction of customary closing conditions related to the proposed financing; and other risks described
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
occur no later than 1:00 p.m., Pacific time, on July 24, 2023, subject to the satisfaction or waiver of all of the conditions set forth in Section 3.2
8-K
EX-4.1
vdalh
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
rclbc7j
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
xb4z t78f
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-10.1
iukdsl
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-99.1
i23jla
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
S-3ASR
EX-4.4
afhrysqb
3 Mar 22
Automatic shelf registration
4:05pm